Real-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of age.
| Autor: | Lupichuk, S.1, Tilley, D.2 derek.tilley@albertahealthservices.ca, Kostaras, X.1,2, Joy, A. A.3 |
|---|---|
| Zdroj: | Current Oncology. Jun2016, Vol. 23 Issue 3, p164-170. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|